
Dr Ramnik Xavier - work visits to Groningen
Dr Ramnik Xavier is a long-term collaborator with the Wijmenga research group, working on the genetics of autoimmune diseases, including several gastrointestinal ones. He has now been awarded a grant by the KNAW Visiting Professors program. This will provide him with the opportunity to make work visits to Groningen, starting from Aprl 2013 for a period of one year. Dr. Xavier is Chief of the Gastrointestinal Unit at Massachusetts General Hospital, Director of the Center for the Study of Inflammatory Bowel Disease, and also Kurt Isselbacher Associate Professor of Medicine at Havard Medical School, Boston.
The Xavier research group
The primary research goal of the Xavier Laboratory at Massachusetts General Hospital, Boston, is to discover and understand the function of important mediators and effectors involved in both the innate and adaptive immune systems. Of particular interest are the cellular components and regulatory networks that interact dynamically within temporal, spatial, and pathophysiological contexts of innate immunity. 1. Systems biology of innate and adaptive immunity 2. Functional mapping of pathways associated with Crohn's disease, ulcerative colitis, and diabetes 3. Genetics of Crohn's disease, celiac disease and ulcerative colitis.
See more at http://www.massgeneral.org/research/researchlab.aspx?id=1096
Last modified: | 18 December 2023 08.30 a.m. |
More news
-
24 March 2025
UG 28th in World's Most International Universities 2025 rankings
The University of Groningen has been ranked 28th in the World's Most International Universities 2025 by Times Higher Education. With this, the UG leaves behind institutions such as MIT and Harvard. The 28th place marks an increase of five places: in...
-
05 March 2025
Women in Science
The UG celebrates International Women’s Day with a special photo series: Women in Science.
-
16 December 2024
Jouke de Vries: ‘The University will have to be flexible’
2024 was a festive year for the University of Groningen. In this podcast, Jouke de Vries, the chair of the Executive Board, looks back.